Toxicological Sciences Public Access Policy
Adopted by the Society of Toxicology in May 2005
The public access guidelines recently released by the NIH requests that
authors of all publications resulting from NIH sponsored research deposit
the final accepted version of their manuscripts in PubMed Central within
12 months of the date they are accepted for publication. The policy, which
becomes effective on May 2, 2005, is described in detail at: http://grants1.nih.gov/grants/guide/notice-files/NOT-OD-05-022.html.
Presently, Toxicological Sciences grants free public access to all articles
published in the journal 12 months after printed publication. We understand
that authors will want to comply voluntarily with the NIH policy, and
therefore, we will grant permission to all authors to deposit their accepted
manuscripts in PubMed Central.
For compliance with public access guidelines, authors are permitted to
transmit their manuscripts to PubMed Central after receipt of the URL
providing online access to the final version of the accepted paper. Upon
submission, authors will specify when their final manuscript will be publicly
accessible through PubMed Central. For consistency with current policies
of Toxicological Sciences that grant free public access to all articles
published in the journal 12 months after printed publication, authors
should indicate that the paper will be publicly accessible after 12 months.
Submission instructions for authors can be found at: http://nihms.nih.gov/. Additional information regarding the implementation of the NIH public access policy and the ability to specify when an article is available is at: http://www.nih.gov/about/publicaccess/Finalpublicaccessimplementation031505.htm.
Toxicological Sciences is pursuing the feasibility of offering to automatically
transmit papers directly to NIH as a service to authors in the future.
However, it is not yet clear that NIH can accommodate automated third
party submissions. We are motivated to provide this service to our authors,
and we will continue to monitor developments concerning this and other
issues relating to the PubMed Central Repository. |
